Avita Medical Inc Reports Results For The Quarter Ended In December: Earnings Summary

AVITA Medical

23/02/2024 03:03

* AVITA Medical Inc  AVH.AX  reported a quarterly adjusted
loss
of 12 cents​​ per share for the quarter ended in December.  The
lone analyst forecast for the quarter was for a loss of 29 cents
per share. Wall Street expected results to range from -48 cents
to -25 cents per share.
    * Revenue was $14.20 million​; analysts expected $14.50
million. 
    * AVITA Medical Inc's reported EPS for the quarter was a
loss of 6
cents​.
    * The company reported a quarterly loss of $7.07 million.
    * AVITA Medical Inc shares had risen by 23.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for AVITA Medical Inc
is A$6.38 
This summary was machine generated from LSEG data February 23 at
03:02 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.38          -0.06          Beat
 Sep. 30 2023      -0.41          -0.07          Beat
 Jun. 30 2023      -0.34          -0.08          Beat
 Mar. 31 2023      -0.33          -0.07          Beat